LISSETTE RIVAS SIRACUSA: Open Payments
NPI 1750804316 · NORWALK, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,251 in 49 payments from 17 companies in 2025. Trend: 2023 $53 · 2024 $367 · 2025 $1,251
Food & beverage: $1,251
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 10 | $221 |
| Merck Sharp & Dohme LLC | 4 | $195 |
| UROGEN PHARMA, INC. | 7 | $168 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $105 |
| Astellas Pharma US Inc | 4 | $97 |
| TOLMAR, INC. | 3 | $81 |
| ABBVIE INC. | 3 | $77 |
| Boston Scientific Corporation | 3 | $77 |
| Endo USA, Inc. | 2 | $44 |
| PFIZER INC. | 1 | $36 |
Products named: KEYTRUDA, Xtandi, JELMYTO, ORGOVYX, Nubeqa, GEMTESA, JATENZO, BOTOX.
Industry payments across CT — which companies pay providers there.
